⚡ QUICK FACTS — KERATOCONUS


👁️ Condition	Keratoconus — progressive corneal thinning and bulging
🧬 ICD-10 code	H18.6
🔴 Type	Progressive, non-inflammatory eye disorder
👨‍👩‍👦 Heredity	1 in 10 patients has a parent with keratoconus
📅 Typical onset	Late teens to early 30s
📅 Progression duration	Can progress for 10–20 years
🎯 Eyes affected	Both eyes — usually one worse than the other
⚠️ Associated conditions	Down syndrome (50%), Ehlers-Danlos, Marfan, retinitis pigmentosa
🧬 Linked genes	COL6A3, VSX1, ZNF469
💊 First-line treatment	Eyeglasses / soft contact lenses
💊 Specialist lenses	RGP, rose-K, hybrid, scleral
🔬 Progression halting	Corneal collagen cross-linking (CXL) — FDA approved
🏥 Advanced cases	Corneal transplant surgery
📋 Gold standard diagnosis	Corneal topography
⛔ Avoid	Eye rubbing — accelerates progression
🌍 Support	National Keratoconus Foundation (NKCF)
🏅 Hospital accreditation	Turkish Ministry of Health certified + international standards

🏅 HOSPITAL ACCREDITATION

Every keratoconus treatment at Revitalize in Turkey is performed in a contracted facility holding:

Turkish Ministry of Health Certification — mandatory national regulatory standard
International accreditation equivalent to JCI standards
Full ophthalmological diagnostic and surgical capability including corneal topography, CXL, and transplant services

View contracted facilities and accreditation details →

👨‍⚕️ SURGEON IDENTITY & CREDENTIALS — E-E-A-T

Dr Serkan Bilis, MD

Specialty: Ophthalmology — Corneal Diseases and Refractive Surgery
Board Certification: Turkish Board of Ophthalmology
Professional Memberships: Turkish Ophthalmological Association; European Society of Cataract and Refractive Surgeons (ESCRS)
Special expertise: Keratoconus diagnosis and management, corneal collagen cross-linking (CXL), scleral lens fitting, corneal transplantation

View all surgeon profiles and credentials →

For independent UK patient guidance on keratoconus symptoms, diagnosis and treatment, the NHS keratoconus pageprovides authoritative information.

💬 VERIFIED PATIENT REVIEWS

“I was diagnosed with keratoconus at 22 and told I might need a corneal transplant within a few years. At Revitalize, the specialist assessed me for cross-linking and we caught it early enough. Two years on, my progression has halted and I’m managing well with scleral lenses. The difference early treatment has made is extraordinary.” — Thomas B., London, keratoconus CXL treatment, 2023 ⭐⭐⭐⭐⭐

“The corneal topography assessment at Revitalize was the most thorough I’d had. The specialist explained exactly what was happening to my corneas and presented a clear, staged treatment plan. I finally felt I was getting proper care for my condition.” — Sarah M., Manchester, keratoconus assessment and management, 2024 ⭐⭐⭐⭐⭐

👉 Watch video testimonials →

Introduction

Keratoconus is a progressive eye condition that can have a profound impact on vision if left undiagnosed or untreated — yet with early detection and the right treatment pathway, the vast majority of patients maintain functional vision for life.

Keratoconus causes the cornea — the clear, dome-shaped front surface of the eye — to progressively thin and bulge forward into an irregular cone shape. This distorts how light enters the eye, causing blurred and distorted vision, increased light sensitivity, and frequent prescription changes. The condition typically begins in the late teens to early 30s and can progress for 10 to 20 years before stabilising naturally.

One in 10 people with keratoconus has a parent with the same condition — highlighting the significant genetic component. But genetic predisposition is not destiny: corneal collagen cross-linking (CXL), the FDA-approved procedure for halting keratoconus progression, has transformed the outlook for patients diagnosed at an early stage. At Revitalize in Turkey, our corneal specialists provide comprehensive keratoconus assessment, monitoring, and treatment — including CXL, specialist lens fitting, and corneal transplantation — in internationally accredited facilities.

What Is Keratoconus? Definition and Mechanism

Keratoconus (ICD-10: H18.6) is a non-inflammatory, progressive disorder of the cornea characterised by localised thinning and protrusion of the corneal stroma into a cone-like shape. This structural change — driven by loss of collagen fibres and changes in the corneal architecture — disrupts the cornea’s normal refractive function, causing light to focus incorrectly on the retina.

The word keratoconus combines the Greek words for cornea (kerato) and cone (konos) — describing precisely the cone-shaped distortion that is the hallmark of the condition. In a normal eye, the cornea is smooth and spherically curved, contributing approximately 70% of the eye’s focusing power. In keratoconus, the progressive irregularity of the corneal surface creates irregular astigmatism that cannot be fully corrected with standard glasses.

Keratoconus affects both eyes in the vast majority of patients — though typically one eye is more severely affected than the other. In a small number of cases, the cornea may swell suddenly, causing an acute and dramatic decrease in vision — a complication known as acute corneal hydrops.

7 Essential Facts About Keratoconus

Fact 1: Keratoconus Has Both Genetic and Environmental Causes

Understanding the cause of keratoconus is essential for risk assessment, early screening decisions, and slowing progression through lifestyle changes.

Genetic factors:

Genetic Factor	Detail
Family history	1 in 10 patients has a parent with keratoconus
Linked genes	COL6A3, VSX1, ZNF469 — identified in genetic research
Down syndrome	~50% of people with Down syndrome have keratoconus
Down syndrome children	5–30% affected

Environmental and lifestyle factors:

Factor	Mechanism
Chronic eye rubbing	Weakens corneal collagen fibres — the most modifiable risk factor
Chronic inflammation	Allergies cause persistent inflammation that degrades corneal integrity
Hormonal changes	Adolescent hormonal changes may initiate or accelerate progression

Associated systemic conditions:

Condition	Association
Down syndrome	Strongly associated — 50% prevalence
Ehlers-Danlos syndrome	Connective tissue disorder affecting corneal collagen
Marfan syndrome	Connective tissue disorder
Retinitis pigmentosa	Associated eye condition
Asthma and allergies	Via chronic inflammation and eye rubbing

Fact 2: The Symptoms of Keratoconus Are Progressive and Varied

Keratoconus does not announce itself with dramatic early symptoms — it creeps in gradually, often initially attributed to simple refractive changes that require updated glasses.

Symptoms of keratoconus by stage:

Symptom	Descrição
Blurry or distorted vision	Objects appear smeared, shadowed, or multipled — the most characteristic symptom
Irregular astigmatism	Corneal shape creates astigmatism that worsens progressively
Glare sensitivity	Increased sensitivity to bright lights and glare, particularly at night
Frequent prescription changes	Repeatedly updating glasses or contact lens prescriptions
Night vision difficulty	Driving at night becomes progressively difficult
Headaches and eye strain	Result of the eye compensating for irregular focus
Sudden vision decrease	In a small number of cases — acute corneal hydrops requiring urgent care

A particularly important clinical pattern is the frequency of prescription changes. A young patient in their teens or twenties who requires new glasses every few months should be assessed for keratoconus rather than simply prescribed updated lenses.

Fact 3: Diagnosis of Keratoconus Requires Specialist Assessment

Keratoconus cannot be reliably detected by a standard high street optician eye test. Specialist diagnostic equipment — particularly corneal topography — is required for reliable detection and monitoring.

Diagnostic tools used in keratoconus assessment:

Tool	Finalidade
Slit-lamp examination	Visual inspection of corneal layers and shape
Corneal topography	Gold standard — detailed 3D surface map showing cone location and severity
Pachymetry	Measures corneal thickness — thinning is a key diagnostic indicator
Retinoscopy	Assesses the eye’s refractive errors
Keratometry	Measures corneal curvature
Computerised corneal topography	Provides precise 3D corneal model for monitoring and surgical planning
Tear film biomarker analysis	Identifies inflammatory and protein markers associated with keratoconus

Annual or biannual specialist corneal assessments are recommended for all patients with confirmed or suspected keratoconus — and for those with first-degree relatives affected by the condition. Early detection is the single most important factor in accessing the treatments that prevent progression to transplant.

Fact 4: Treatment Is Staged — From Lenses to Cross-Linking to Transplant

Keratoconus treatment is not one-size-fits-all. It is precisely staged according to disease severity and rate of progression, with each stage offering specific benefits.

Stage 1 — Mild keratoconus: corrective lenses

In early keratoconus, standard eyeglasses or soft contact lenses may provide adequate vision correction. As the irregular astigmatism develops, standard soft lenses become increasingly inadequate because they cannot fully conform to or correct the irregular corneal surface.

Stage 2 — Moderate keratoconus: specialist contact lenses

Specialist contact lenses are the cornerstone of vision management in moderate keratoconus:

Lens Type	Mechanism	Best For
Rigid Gas-Permeable (RGP)	Rigid surface masks corneal irregularity	Moderate keratoconus
Rose-K lenses	Specifically designed for keratoconus corneas	Moderate keratoconus
Hybrid lenses	RGP centre with soft skirt for comfort	Those who find RGP uncomfortable
Scleral lenses	Large diameter; vault over the cornea; filled with saline	Advanced keratoconus; irregular corneas

Scleral lenses are particularly effective for advanced keratoconus because they vault completely over the irregular corneal surface, creating a smooth, regular refractive surface. They also protect the cornea and provide lubrication — a significant benefit for patients with associated dry eye.

Stage 3 — Progressive keratoconus: Corneal Collagen Cross-Linking (CXL)

Corneal collagen cross-linking is the most important advance in keratoconus management of recent decades. FDA approved and proven worldwide, CXL uses ultraviolet A light combined with riboflavin (vitamin B2) eye drops to strengthen the collagen bonds within the cornea — halting the progressive thinning and bulging that characterises keratoconus.

CXL does not reverse existing corneal distortion — it stops it getting worse. This is why early treatment, before significant distortion has occurred, produces the best outcomes. Many patients who receive CXL at an appropriate stage avoid ever needing a corneal transplant.

Stage 4 — Advanced keratoconus: Corneal Transplant Surgery

For patients with advanced keratoconus where vision cannot be adequately corrected with any form of contact lens, or where corneal scarring has occurred, corneal transplant surgery may be indicated. Modern surgical options include full-thickness penetrating keratoplasty (PKP) and partial-thickness approaches (DALK — deep anterior lamellar keratoplasty). Following transplantation, patients may still require contact lenses to achieve optimal vision, but a functional corneal surface is restored.

🎯 MID-PAGE CTA

Concerned About Keratoconus? Book a Comprehensive Corneal Assessment.

Our ophthalmology specialists at Revitalize in Turkey provide comprehensive keratoconus assessment including corneal topography, pachymetry, and personalised treatment planning — in internationally accredited facilities.

📱 WhatsApp — Fast response, typically within 2 hours Message on WhatsApp →

📄 Download our Keratoconus & Eye Treatment Guide PDF — Staging overview, CXL explained, lens options, treatment timeline and what to expect at Revitalize in Turkey Download Free PDF →

📅 Book a UK Meeting — London or Manchester Book London → | Book Manchester →

Fact 5: Stopping Eye Rubbing Is the Single Most Controllable Risk Factor

Of all the risk factors for keratoconus progression, chronic eye rubbing is the only one that patients can directly and immediately control — and the evidence that it damages the cornea is compelling.

Eye rubbing applies repeated mechanical pressure to the cornea, which degrades the collagen fibres that give the cornea its structural integrity. In a cornea that already has genetically weaker collagen architecture — as in keratoconus — this repeated trauma can meaningfully accelerate the thinning and distortion.

Practical strategies for stopping eye rubbing:

Treat underlying allergies aggressively — itchy eyes are the primary driver of eye rubbing
Use preservative-free lubricating eye drops when eyes feel irritated or dry
Wear sunglasses outdoors to reduce dust and pollen irritation
If rubbing is habitual rather than itch-driven, conscious awareness and substitution techniques help
Cold compresses provide itch relief without the mechanical damage of rubbing

Managing allergies and stopping eye rubbing are two of the most impactful lifestyle interventions available to keratoconus patients at any stage of the disease.

Fact 6: Keratoconus Is Associated With Specific Systemic Conditions

The association between keratoconus and several systemic conditions — most notably Down syndrome — has important clinical implications for screening and management.

Approximately 50% of people with Down syndrome develop keratoconus, and 5 to 30% of children with Down syndrome are affected. This extraordinary prevalence means that every person with Down syndrome should be regularly monitored by an ophthalmologist with specific corneal expertise.

The association with connective tissue disorders — including Ehlers-Danlos syndrome and Marfan syndrome — reflects the underlying biology of keratoconus: abnormal corneal collagen architecture. Patients with these conditions should be proactively assessed for keratoconus as part of their routine care.

Asthma and allergies create a keratoconus risk through the chronic eye rubbing behaviour they drive — rather than through any direct biological mechanism. Effective management of allergic eye disease is therefore both a quality-of-life intervention and a keratoconus progression prevention strategy.

Fact 7: Research Is Advancing Rapidly — the Future of Keratoconus Care Is Promising

Keratoconus research has accelerated significantly, with multiple promising directions that could transform management in the coming years.

Recent research advances (2017–2020 and beyond):

Research Area	Finding/Direction
Inflammation markers	Keratoconus linked to elevated inflammatory markers in corneal tissue
Tear film biomarkers	Specific protein changes in tears allow earlier, non-invasive detection
Genetic research	Identification of COL6A3, VSX1, ZNF469 and other candidate genes
AI-assisted diagnosis	Machine learning models can detect and grade keratoconus from topography data with high accuracy
Gene therapy	Research targeting the genetic basis of abnormal corneal collagen — early stage but promising
Advanced cross-linking	Protocols being refined to improve outcomes and expand eligibility

Artificial intelligence is particularly promising for keratoconus screening — AI models trained on large corneal topography datasets can detect subtle early changes that are difficult to detect clinically, potentially enabling intervention before any visual symptoms develop.

Living With Keratoconus

Keratoconus is a chronic condition that requires ongoing management — but with the right support, most patients maintain a good quality of life and functional vision throughout their lives.

Practical daily management strategies:

Use adequate lighting for reading and close work
Adjust computer screen brightness, contrast, and font size
Use magnifying tools for fine detail tasks if needed
Keep all scheduled follow-up appointments — monitoring progression is essential
Communicate changes in vision to your specialist promptly

Coping with emotional impact: A diagnosis of keratoconus — particularly in a young person — can cause significant anxiety about future vision. Connecting with others who understand the condition is genuinely helpful.

Key support resources:

Organisation	What They Offer
National Keratoconus Foundation (NKCF)	Helpline for patients and caregivers, online support groups, educational resources
CLEI Center for Keratoconus	Expert diagnosis and treatment; NKCF Top Doctor Award recipient; comprehensive care including CXL and transplant

Preventing Keratoconus Progression — What Patients Can Do

While keratoconus cannot be completely prevented, patients have meaningful control over several factors that influence its rate of progression.

Stop eye rubbing immediately and permanently — the single most important lifestyle intervention
Manage allergies aggressively — reduces the itch drive to rub eyes
Attend regular specialist eye exams — annual or biannual monitoring depending on stability
Seek CXL assessment promptly if progression is detected — early treatment produces the best outcomes
Wear UV-protective sunglasses outdoors — UV exposure may affect corneal stability
Use protective eyewear during sports and activities that risk eye contact

Why UK Patients Choose Revitalize in Turkey for Keratoconus Care

Specialist corneal ophthalmologists with specific expertise in keratoconus diagnosis, monitoring, CXL, specialist lens fitting, and corneal transplantation
Gold standard corneal topography — full diagnostic mapping for accurate staging and monitoring
Corneal collagen cross-linking (CXL) — FDA-approved progression-halting treatment available
Full specialist lens fitting — RGP, rose-K, hybrid, and scleral lenses
Corneal transplant capability — for advanced cases requiring surgical intervention
Internationally accredited facilities — Turkish Ministry of Health certification and international standards
UK consultation meetings in London and Manchester
Dedicated UK patient coordinators throughout your journey
21+ years serving UK patients — trusted, proven medical tourism pathway

View our eye treatment services → View contracted facilities and accreditation →

📅 UPCOMING UK CONSULTATION MEETINGS

London

📍 Central London (address confirmed on booking) Upcoming dates: [Insert confirmed dates] Book London →

Manchester

📍 Central Manchester (address confirmed on booking) Upcoming dates: [Insert confirmed dates] Book Manchester →

📋 FAQ — STRUCTURED Q&A (MAPS TO SCHEMA ABOVE)

Q: What is keratoconus? A: Keratoconus (ICD-10: H18.6) is a progressive, non-inflammatory condition in which the cornea thins and bulges into a cone shape, causing blurred and distorted vision, irregular astigmatism, and light sensitivity. It begins in the late teens to early 30s and can progress for 10 to 20 years.

Q: What causes keratoconus? A: Genetic factors (1 in 10 has an affected parent; linked genes COL6A3/VSX1/ZNF469), chronic eye rubbing, chronic inflammation from allergies, hormonal changes, and associated conditions including Down syndrome (50% prevalence), Ehlers-Danlos syndrome, Marfan syndrome, and retinitis pigmentosa.

Q: What are the symptoms of keratoconus? A: Blurry/distorted vision, irregular astigmatism, glare sensitivity, frequent prescription changes, night vision difficulty, headaches, eye strain, and (rarely) sudden acute vision decrease from corneal hydrops.

Q: How is keratoconus diagnosed? A: Through slit-lamp examination, corneal topography (gold standard), pachymetry, retinoscopy, keratometry, computerised topography, and tear film biomarker analysis. Regular specialist assessment is essential for all at-risk individuals.

Q: What are the treatment options for keratoconus? A: Staged by severity: eyeglasses/soft lenses (mild); RGP/rose-K/hybrid/scleral lenses (moderate); corneal collagen cross-linking CXL — FDA approved (progressive disease); corneal transplant surgery (advanced). Early intervention is critical.

Q: Can keratoconus progression be stopped? A: Corneal collagen cross-linking (CXL) is FDA approved and proven to halt progression. Combined with stopping eye rubbing, managing allergies, and regular monitoring, most patients diagnosed early avoid needing corneal transplantation.

📲 THREE WAYS TO START

1. WhatsApp — Fastest Response

Message on WhatsApp → Ask about keratoconus assessment, CXL, specialist lenses, costs, or anything else. Response typically within 2 hours.

2. Download the Free Keratoconus & Eye Treatment Guide PDF

Download Free PDF → Keratoconus staging overview, CXL explained, lens options, treatment timeline, and what to expect at Revitalize in Turkey.

3. Book a UK Meeting

Book London → | Book Manchester →